CS
Candriam SCA Portfolio holdings
AUM
$17.3B
1-Year Return
21.68%
This Quarter Return
+1.91%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$14.7B
AUM Growth
+$98M
(+0.67%)
Cap. Flow
+$48.4M
Cap. Flow
% of AUM
0.33%
Top 10 Holdings %
Top 10 Hldgs %
22.12%
Holding
956
New
63
Increased
332
Reduced
303
Closed
69
Top Buys
| 1 |
Johnson & Johnson
JNJ
|
$54.5M |
| 2 |
AstraZeneca
AZN
|
$46.3M |
| 3 |
Autodesk
ADSK
|
$40.5M |
| 4 |
Mercado Libre
MELI
|
$39.4M |
| 5 |
Amazon
AMZN
|
$31.1M |
Top Sells
| 1 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$92.5M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
$85.8M |
| 3 |
Alibaba
BABA
|
$60.1M |
| 4 |
Merck
MRK
|
$49.2M |
| 5 |
MXIM
Maxim Integrated Products
MXIM
|
$48.5M |
Sector Composition
| 1 | Healthcare | 32.1% |
| 2 | Technology | 24.54% |
| 3 | Financials | 9.08% |
| 4 | Communication Services | 8.24% |
| 5 | Consumer Discretionary | 7.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
376
Ford
F
$46.7B
| $5.54M | 0.04% |
391,575
+37,560
| +11% | +$532K |
|
377
General Motors
GM
$55.5B
| $5.51M | 0.04% |
104,615
-5,900
| -5% | -$311K |
|
378
VTEX
VTEX
$744M
| $5.49M | 0.04% |
+267,000
| New | +$5.49M |
|
|
PVLA
379
Palvella Therapeutics, Inc. Common Stock
PVLA
$616M
| $5.49M | 0.04% |
13,273
| – | – |
|
380
Marsh & McLennan
MMC
$100B
| $5.48M | 0.04% |
36,157
-2,009
| -5% | -$304K |
|
381
Truist Financial
TFC
$60B
| $5.35M | 0.04% |
91,215
-2,045
| -2% | -$120K |
|
382
Teladoc Health
TDOC
$1.38B
| $5.34M | 0.04% |
42,130
+4,206
| +11% | +$533K |
|
383
Dyne Therapeutics
DYN
$2.02B
| $5.25M | 0.04% |
323,393
| – | – |
|
384
Snowflake
SNOW
$75.3B
| $5.17M | 0.04% |
17,106
-531
| -3% | -$161K |
|
385
Fiserv
FI
$73.4B
| $5.17M | 0.04% |
47,621
+2,126
| +5% | +$231K |
|
386
Macy's
M
$4.64B
| $5.14M | 0.03% |
+227,508
| New | +$5.14M |
|
387
Hershey
HSY
$37.6B
| $5.14M | 0.03% |
30,343
-1,590
| -5% | -$269K |
|
388
Baidu
BIDU
$35.1B
| $5.11M | 0.03% |
33,248
-157,341
| -83% | -$24.2M |
|
389
Assembly Biosciences
ASMB
$183M
| $5.11M | 0.03% |
122,404
+29,591
| +32% | +$1.24M |
|
390
Y-mAbs Therapeutics
YMAB
$390M
| $5.09M | 0.03% |
178,181
| – | – |
|
391
Old Dominion Freight Line
ODFL
$31.7B
| $5.07M | 0.03% |
35,450
+2,062
| +6% | +$295K |
|
392
Axsome Therapeutics
AXSM
$6.25B
| $5.06M | 0.03% |
153,602
+35,000
| +30% | +$1.15M |
|
393
US Bancorp
USB
$75.9B
| $5.04M | 0.03% |
84,742
-2,094
| -2% | -$124K |
|
394
Sempra
SRE
$52.9B
| $5.03M | 0.03% |
79,466
+3,264
| +4% | +$206K |
|
|
RDUS
395
DELISTED
Radius Health, Inc.
RDUS
| $5M | 0.03% |
403,068
| – | – |
|
396
XP
XP
$9.96B
| $4.98M | 0.03% |
124,000
+74,000
| +148% | +$2.97M |
|
|
SOLY
397
DELISTED
Soliton, Inc.
SOLY
| $4.87M | 0.03% |
239,086
+171,316
| +253% | +$3.49M |
|
398
Bruker
BRKR
$4.68B
| $4.85M | 0.03% |
62,128
| – | – |
|
399
CME Group
CME
$94.4B
| $4.8M | 0.03% |
24,831
+553
| +2% | +$107K |
|
|
DFS
400
DELISTED
Discover Financial Services
DFS
| $4.8M | 0.03% |
39,053
+13,923
| +55% | +$1.71M |
|